Chief Scientific Advisors Update on the State of Breast Cancer Research
Susan G. Komen chief scientific advisors discuss COVID-19’s impact on breast cancer research.
Cancer Updates
Susan G. Komen chief scientific advisors discuss COVID-19’s impact on breast cancer research.
Major breast cancer news was announced at the 2020 European Society of Medical Oncology.
Dr. Nadine Tung led a clinical trial to determine if there was a better treatment option for breast cancer patients who inherited BRCA1/2 gene mutations.
Susan G. Komen’s Kari Wojtanik shares what it was like to get screened for colon cancer during COVID-19.
Susan G. Komen’s David Vaught tells us why vaccines are important for the flu, COVID-19 and breast cancer.
National Breast Cancer Awareness Month is about more than awareness of the disease.
Komen Scholar Joe Gray has a unique and personal perspective on treating breast cancer patients after his wife’s metastatic breast cancer diagnosis.
Sherene Loi, FRACP, Ph.D., talked to Susan G. Komen about a clinical trial could immediately change the treatment options for some metastatic breast cancer patients.
There’s been a lot of news lately. So much news that if you haven’t been following every headline, every day of the week, you might have missed something. But that’s why I’m here. As the Manager of Research Programs at Susan G. Komen, I’ve been keeping up with latest in breast cancer research news. Here’s […]
Susan G. Komen’s recent Facebook Live examined ways patients can protect their health during these times and whether non-symptomatic women should resume getting their annual mammograms.
Susan G. Komen is asking Congress to take action on chemotherapy parity and other important policies for breast cancer patients it its next COVID-19 relief bill.
The FDA approved another new drug for the treatment of metastatic breast cancer and new research shows that cancer patients with a lung condition are more likely to die or have serious complications from COVID-19.